These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7544214)

  • 1. Alpha-adrenergic blocking drugs in bladder outflow obstruction: what potential has alpha 1-adrenoceptor selectivity?
    Chapple CR
    Br J Urol; 1995 Jul; 76 Suppl 1():47-55. PubMed ID: 7544214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha adrenoceptor antagonists in the year 2000: is there anything new?
    Chapple CR
    Curr Opin Urol; 2001 Jan; 11(1):9-16. PubMed ID: 11148741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPH.
    de Mey C
    Eur Urol; 1998; 34 Suppl 2():18-28; discusion 47. PubMed ID: 9732829
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract]   [Full Text] [Related]  

  • 6. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-blockers and lower urinary tract function: more than smooth muscle relaxation?
    Michel MC; Schafers RF; Goepel M
    BJU Int; 2000 Oct; 86 Suppl 2():23-8; discussion 28-30. PubMed ID: 11501614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urodynamic study of lower urinary tract. VI. Clinical application of alpha adrenergic blocker for the treatment of benign prostatic hypertrophy and bladder neck contracture (author's transl)].
    Kondo A; Narita H; Otani T; Kobayashi M; Takita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1232-40. PubMed ID: 83419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results].
    Oelke M; Höfner K; Berges RR; Jonas U
    Urologe A; 2002 Sep; 41(5):425-41. PubMed ID: 12426859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of benign prostatic hyperplasia].
    Vahlensieck W; Fabricius PG; Hell U
    Fortschr Med; 1996 Nov; 114(31):407-11. PubMed ID: 9036092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials.
    Kortmann BB; Floratos DL; Kiemeney LA; Wijkstra H; de la Rosette JJ
    Urology; 2003 Jul; 62(1):1-9. PubMed ID: 12837408
    [No Abstract]   [Full Text] [Related]  

  • 13. [Established and upcoming new options in medical therapy for benign prostatic hyperplasia].
    Schlenker B; Beer AM; Gratzke C; Tilki D; Seitz M; Stief CG; Reich O
    MMW Fortschr Med; 2009 Oct; 151(41):33-6. PubMed ID: 19891182
    [No Abstract]   [Full Text] [Related]  

  • 14. [alpha 1-receptor blockade in therapy of benign prostatic hyperplasia syndrome. Correct dosing for optimal effectiveness].
    Berges RR; Michel MC; Jonas U
    Urologe A; 2002 Sep; 41(5):452-7. PubMed ID: 12426862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].
    MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14725041
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha 1-adrenoceptor selectivity: clinical or theoretical benefit?
    Lepor H
    Br J Urol; 1995 Jul; 76 Suppl 1():57-61. PubMed ID: 7544216
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on "Wada N, Kita M, Hashizume K, et al. Urodynamic effects of dutasteride add-on therapy to alpha-adrenergic antagonist for patients with benign prostatic enlargement: prospective pressure-flow study. Neurourol Urodyn 2013;32:1123-7".
    Oelke M
    Neurourol Urodyn; 2013 Nov; 32(8):1128-9. PubMed ID: 23192914
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of terazosin on clinical benign prostatic hyperplasia in older adults.
    Mudiyala R; Ahmed A
    J Am Geriatr Soc; 2003 Mar; 51(3):424-6. PubMed ID: 12588590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.